Compare billed units against service notes to catch rounding errors before they become denial patterns
People following vegetarian or vegan diets, those with absorption disorders, older adults, and individuals with certain medical conditions are at higher risk for deficiency
BPC-157 is not FDA-approved and was nominated for, then removed from, 503B bulk-compounding eligibility in 2024 based on FDA's safety review
Patients interested in telemedicine products must consent to a review of Telemedicine waiver is reviewed by our providers before orders are sent for compounding.
Manufactured by Amros Pharmaceuticals, it ensures quality, safety, and efficacy for both IM and IV administration
These compounds could potentially complement 5-amino-1mq in protocols focused on metabolic health